Cancer R&D 2024 has wrapped up successfully. We’re grateful for your interest and interaction with Alfa Cytology. We’re eager to continue providing our expertise in cancer drug development. Let’s look back on these memorable moments!
Learn More
Leukemia is a broad term encompassing a group of diseases characterized by the uncontrolled proliferation and abnormal differentiation of white blood cells, resulting in a malignant tumor within the blood system. According to the rate of onset and source of leukemia, leukemia can be divided into four main types, namely acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphoblastic leukemia (CLL), and chronic myeloid leukemia (CML). Although leukemia has been studied extensively, the causes of leukemia are not fully understood but are associated with a variety of genetic and environmental risk factors. Chromosomal abnormalities in leukemia lead to the disorder of gene expression regulation, triggering the downstream signaling pathway, resulting in cell proliferation and differentiation dysfunction, resulting in the occurrence of leukemia. Due to the limited healing ability of traditional chemotherapy drugs and the complexity of different types of leukemia, the study of the pathogenesis of leukemia is conducive to the development of targeted drugs and provides directions for the treatment of leukemia.
Fig. 1. Stem cell basis for myeloid leukemia. (Jordan, C. et al., 2004)
Alfa Cytology provides research services on the pathogenesis of leukemia to support your discovery of the pathogenesis of leukemia. We can optimize and build new and suitable solutions for different leukemia types for you and provide you with consulting services to provide you with effective advice. According to different research content, we provide you with the following services.
Please complete the online inquiry form to learn more about other aspects of leukemia pathogenesis.
Alfa Cytology offers a wide range of research services, from oncogene research to the development of leukemia. If you cooperate with us, we can provide you with customized leukemia pathogenesis solutions, providing sufficient insights to support your leukemia treatment drug development process. Our expertise and efficient services accelerate your success. Please contact us if you have any special requirements about our pathogenesis of leukemia services.
Reference